The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Update with Oramed Pharmaceuticals - Platform Technology Company Discusses Clinical Development, Target Indications and Value Catalysts

SNNLive caught up with Nadav Kidron, CEO of Oramed Pharmaceuticals (NASDAQ: ORMP) at the BIO CEO & Investor Conference 2018 in New York City, NY.

Share With

Wednesday, April 04, 2018

   

© 2018 Stock News Now